Extended-Release Carbamazepine Capsules in Bipolar I Disorder: Profile Report

Author： Tracy Swainston Harrison   Keating Gillian M.  

Publisher： Adis International

ISSN： 1175-9038

Source： American Journal of Drug Delivery, Vol.4, Iss.1, 2006-01, pp. : 51-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-Release Carbamazepine Capsules: In Bipolar I Disorder

By Tracy Swainston Harrison   Keating Gillian M.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 709-716

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules as Monotherapy in Bipolar Disorder: Pooled Results from Two Randomised, Double-Blind, Placebo-Controlled Trials

By Weisler Richard H.   Hirschfeld Robert  

CNS Drugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 219-231

Adis International

Access to resources Recommend Favorite

Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†: Profile Report

By Croxtall Jamie D.  

CNS Drugs, Vol. 26, Iss. 3, 2012-03 ,pp. : 277-279

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: A Viewpoint by Richard H. Weisler

By Weisler Richard H.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 717-718

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder

By >  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 751-764

Adis International

Access to resources Recommend Favorite